MTOR and Parkinson disease: In both the rotenone-induced rat model of PD with acute toxicity and rotenone-induced mice model of PD with chromic toxicity, corynoxine has been proved to not only decrease α-synuclein aggregates through mTOR-mediated autophagy but also diminish neuroinflammation (Chen et al., 2021).